Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Phillip W
Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P (2009) Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis
The FDA classifies it as a Category 2 bulk drug substance, noting potential safety concerns in unregulated compounding
Frequency: protocols commonly involve weekly sessions for 812 weeks, then monthly maintenance tailored to your response
US$ 27.28
US$ 24.92
US$ 27.97
US$ 29.32
US$ 26.99
US$ 27.10
US$ 26.09
US$ 25.31
US$ 28.50
US$ 28.15
